A randomized phase II study of SM-88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond.

Marcus S NoelSemmie KimMarion L HartleySteve WongVincent J PicozziHarry StaszewskiDae Won KimJan M Van TornoutPhilip Agop PhilipVincent ChungAllyson J OceanAndrea Wang-Gillam

Published in: Cancer medicine (2022)

gov Identifier: NCT03512756.

Keyphrases

phase ii study
open label
locally advanced
placebo controlled
rectal cancer
squamous cell carcinoma
newly diagnosed
clinical trial
randomized controlled trial
radiation therapy
study protocol